SEC Form 4 · accession 0001645627-17-000036
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 17, 2017
Accepted (ET)
Apr 19, 2017 · 9:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0495 | A | 20,177,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0499 | A | 20,178,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0499 | A | 20,179,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0528 | A | 20,180,849 | D | |
| Common Stock | Apr 17, 2017 | P | 700 | $0.0528 | A | 20,181,549 | D | |
| Common Stock | Apr 17, 2017 | P | 300 | $0.0596 | A | 20,181,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.055 | A | 20,182,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.054 | A | 20,183,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0549 | A | 20,184,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0549 | A | 20,185,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0577 | A | 20,186,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0577 | A | 20,187,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0574 | A | 20,188,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0577 | A | 20,189,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0577 | A | 20,190,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0569 | A | 20,191,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.054 | A | 20,192,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.054 | A | 20,193,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.052 | A | 20,194,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.052 | A | 20,195,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.052 | A | 20,196,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0502 | A | 20,197,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0517 | A | 20,198,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.051 | A | 20,199,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.051 | A | 20,200,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.052 | A | 20,201,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.05 | A | 20,202,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0539 | A | 20,203,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.052 | A | 20,204,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.052 | A | 20,205,849 | D |
Table II — derivative securities
No Table II lines on this filing.